ACTIO BIOSCIENCES
Live / Allowed — Approved for publication (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99479295
- Mark type
- Stylized text
- Filed
- 04 Nov 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: (Based on Intent To Use)Pharmaceutical preparations for the treatment of rare diseases and neurological disorders, namely epilepsy and developmental and epileptic encephalopathies (DEEs), neuromuscular disorders, Charcot Marie Tooth disease, and overactive bladder
- Class 042 — Scientific and technological services: (Based on Use in Commerce)Drug discovery services; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields
Owner
- Actio Biosciences, Inc., San Diego, CA, US
Prosecution history
- 08 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Jun 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 18 Jun 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 18 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION WRITTEN
- 17 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Nov 2025 — NEW APPLICATION ENTERED